Advisory Board


Meltzer 150p.png

David Meltzer, Ph.D., M.D.
University of Chicago

David O. Meltzer, Ph.D., M.D., is Chief of the Section of Hospital Medicine, Director of the Center for Health and the Social Sciences, and Chair of the Committee on Clinical and Translational Science at the University of Chicago, where he is Professor in the Department of Medicine, and affiliated faculty at the University of Chicago Harris School of Public Policy and the Department of Economics. Meltzer’s research explores problems in health economics and public policy with a focus on the theoretical foundations of medical cost-effectiveness analysis and the cost and quality of hospital care. Meltzer has performed randomized trials comparing the use of doctors who specialize in inpatient care (“hospitalists”). He is currently leading a Centers for Medicaid and Medicare Innovation Challenge award to study the effects of improved continuity in the doctor patient relationship between the inpatient and outpatient setting on the costs and outcomes of care for frequently hospitalized Medicare patients. He led the formation of the Chicago Learning Effectiveness Advancement Research Network (Chicago LEARN) that helped pioneer collaboration of Chicago-Area academic medical centers in hospital-based comparative effectiveness research and the recent support of the Chicago Area Patient Centered Outcomes Research Network (CAPriCORN) by the Patient Centered Outcomes Research Institute (PCORI).

Meltzer received his M.D. and Ph.D. in economics from the University of Chicago and completed his residency in internal medicine at Brigham and Women’s Hospital in Boston. Meltzer is the recipient of numerous awards, including the Lee Lusted Prize of the Society for Medical Decision Making, the Health Care Research Award of the National Institute for Health Care Management, and the Eugene Garfield Award from Research America. Meltzer is a research associate of the National Bureau of Economic Research, elected member of the American Society for Clinical Investigation, and past president of the Society for Medical Decision Making. He has served on several IOM panels, include one examining U.S. organ allocation policy and the recent panel on the Learning Health Care System that produced Best Care at Lower Cost. He also has served on the DHHS Secretary’s Advisory Committee on Healthy People 2020, the Patient Centered Outcomes Research Institute (PCORI) Methodology Committee, as a Council Member of the National Institute for General Medical Studies, and as a health economics advisor for the Congressional Budget Office.

Bortz 150p.png

Beth Bortz
President, Virginia Center for Health Innovation

Beth Bortz was named the President and CEO of the Virginia Center for Health Innovation (VCHI) in March 2012. Prior to joining VCHI, she served as the Executive Director of the Medical Society of Virginia (MSV) Foundation, where she developed and led programs in health care quality improvement, medication assistance, public health awareness, and physician leadership since 2002. Ms. Bortz also served as Senior Program Officer and Deputy Director of the Virginia Health Care Foundation for seven years and as a Senior Associate Legislative Analyst for the Virginia General Assembly’s Joint Legislative Audit and Review Commission for three years.

Ms. Bortz is a 2007 graduate of LEAD Virginia and recently served as its Alumni Chair. She was a founding board member of Rx Partnership, serving as Board Chair from 2006-2008. She has received several awards and recognition for her work, including: Influential Women of Virginia Award from Virginia Lawyer’s Media; Medallion Award for Community Partnership from Mutual of America; and Stettinius Award for Nonprofit Leadership from the Community Foundation representing Greater Richmond. 

Ms. Bortz earned her undergraduate degree in Economics and Government and her Masters in Public Policy from the College of William and Mary. Most recently she earned a graduate certificate in Non-profit Management from Virginia Commonwealth University.

Steven Teutsch 150p.png

Steven M. Teutsch, M.P.H., M.D.
Adjunct Professor, Fielding School of Public Health, UCLA
Senior Fellow, Public Health Institute
Senior Fellow, Schaeffer Center, USC

Steven M. Teutsch is an independent consultant; Adjunct Professor at the Fielding School of Public Health, UCLA; Senior Fellow at the Public Health Institute; and Senior Fellow, Schaeffer Center, University of Southern California. He was formerly the Chief Science Officer, Los Angeles County Public Health where he worked on evidence-based public health and policy.  He had been in Outcomes Research and Management program at Merck where he was responsible for scientific leadership in developing evidence-based clinical management programs, conducting outcomes research studies, and improving outcomes measurement to enhance quality of care. Prior to joining Merck he was Director of the Division of Prevention Research and Analytic Methods (DPRAM) at CDC where he was responsible for assessing the effectiveness, safety, and the cost-effectiveness of disease and injury prevention strategies.  DPRAM developed comparable methodology for studies of the effectiveness and economic impact of prevention programs, provided training in these methods, developed CDC’s capacity for conducting necessary studies, and provided technical assistance for conducting economic and decision analysis.  The Division also evaluated the impact of interventions in urban areas, developed the Guide to Community Preventive Services, and provided support for CDC’s analytic methods. He has served as a member of that Task Force and the U.S. Preventive Services Task Force which develops the Guide to Clinical Preventive Services as well as on Americas Health Information Community Personalized Health Care Workgroup and the Evaluation of Genomic Applications in Prevention and Practice (EGAPP) Workgroup.  He chaired the Secretary's Advisory Committee on Genetics Health and Society, and served on and has chaired IOM panels, Medicare’s Evidence Development and Coverage Advisory Committee, and formerly on several subcommittees of the Secretary’s Advisory Committee on Healthy People 2020.  He has served on multiple Institute of Medicine panels.

Dr. Teutsch came to CDC in 1977, where he was assigned to the Parasitic Diseases Division and worked extensively on toxoplasmosis.  He was then assigned to the Kidney Donor and subsequently the Kidney Disease Program.  He developed the framework for CDC's diabetes control program.  He joined the Epidemiology Program Office and became the Director of the Division of Surveillance and Epidemiology where he was responsible for coordinating CDC's disease monitoring activities.  He became Chief of the Prevention Effectiveness Activity in 1992.

Dr. Teutsch was born in Salt Lake City, Utah.  He received his undergraduate degree in biochemical sciences at Harvard University in 1970, an M.P.H. in epidemiology from the University of North Carolina School of Public Health in 1973, and his M.D. from Duke University School of Medicine in 1974.  He completed his residency training in internal medicine at Pennsylvania State University, Hershey.  He was certified by the American Board of Internal Medicine in 1977, the American Board of Preventive Medicine in 1995, and is a Fellow of the American College of Physicians and American College of Preventive Medicine.  Dr. Teutsch is an Adjunct Professor at the Emory University School of Public Health, Department of Health Policy and Management; U. No. Carolina School of Public Health; adjunct professor at UCLA School of Public Health, and Senior Scholar at the Schaeffer Center at the University of Southern California.